Pharmaceutical GuidelineLearning is lifeEmpowering Excellence in Pharmaceutical Manufacturing
admin@pharmaceuticalguideline.com15 articles
As of January 2026, the Indian pharma sector faces a massive bottleneck: over 13,000 plants require inspection, yet only ~1,100 field inspectors are active. While the government has enforced Revised Schedule M, Laghu Udhyog Bharti is pushing for a vital extension until December 2026 to prevent the closure of thousands of MSMEs and ensure the continued supply of affordable medicine.
Improving productivity & quality is critical to ensuring efficient operations, regulatory compliance & the delivery of high-quality products
Draft guidance for industry entitled “Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products
WHO Expert Committee on Specifications for Pharmaceutical Preparations has published the Technical Report Series TRS 1044 2022 56th Report
Creams are semisolid emulsion dosage forms, Creams are generally intended for external application to the skin or to the mucous membranes
US FDA has revised the guideline for Size, Shape, and other physical Attributes of Generic Tablets and capsules. USFDA Guidelines
List of Major Equipment of Tablets and Capsules Manufacturing
News & UpdatesPIC/S [PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME] has revised guideline No. PE 009-16 [GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS] on 1 February 2022.Key Revision: • Revision of Annex 13 • Annex 13 (Manufacture of investigational medicinal products) • New Annex added • Annex 16 (Authorised person and batch release)Click Here to Download the Guideline Our Dynamic Pharma Team is providing a step-by-step learning topic on this website.You will find Short No
Granules; a General Chapter of British Pharmacopoeia BP and Europian Pharmacopoeia Ph Eur
USP-43 〈1151〉 Films PHARMACEUTICAL DOSAGE FORMS
Aerosols PHARMACEUTICAL DOSAGE FORMS, United State Pharmacopoeia USP-43
〈1151〉 PHARMACEUTICAL DOSAGE FORMS This article is based on the requirement of the United State Pharmacopoeia.
Working document QAS/21.875, February 2021. World Health Organization (WHO) has published the DRAFT WORKING DOCUMENT FOR COMMENTS.
Co-operation Scheme (PIC/S) has revised the guidance document for GMP INSPECTION RELATED TO PAC on 19 January 2021
